GeneMatch: A novel recruitment registry using at‐home APOE genotyping to enhance referrals to Alzheimer's prevention studies
- 13 February 2019
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 15 (4) , 515-524
Abstract
Introduction: Recruitment for Alzheimer's disease (AD) prevention research studies is challenging because of lack of awareness among cognitively healthy adults coupled with the high screen fail rate due to participants not having a genetic risk factor or biomarker evidence of the disease. Participant recruitment registries offer one solution for efficiently and effectively identifying, characterizing, and connecting potential eligible volunteers to studies.Methods: Individuals aged 55‐75 years who live in the United States and self‐report not having a diagnosis of cognitive impairment such as MCI or dementia are eligible to join GeneMatch. Participants enroll online and are provided a cheek swab kit for DNA extraction and apolipoprotein E (APOE) genotyping. Participants are not told their APOE results, although the results may be used in part to help match participants to AD prevention studies.Results: As of August 2018, 75,351 participants had joined GeneMatch. Nearly 30% of participants have one APOE4 allele, and approximately 3% have two APOE4 alleles. The percentages of APOE4 heterozygotes and homozygotes are inversely associated with age (P < .001).Discussion: GeneMatch, the first trial‐independent research enrollment program designed to recruit and refer cognitively healthy adults to AD prevention studies based in part on APOE test results, provides a novel mechanism to accelerate prescreening and enrollment for AD prevention trials.Keywords
Funding Information
- National Institute on Aging (1UF1AG046150)
- Alzheimer's Association
- Flinn Foundation
- National Institute on Aging (UF1 AG046150, R01 AG055444, 1UF1AG046150, 1UF1AG046150, UF1 AG046150, R01 AG055444, P30 AG19610, R01 AG055444, UF1 AG046150, R01 AG031581)
- Alzheimer's Association (API‐16‐388841)
- NIH Office of the Director (UG3OD023171)
- National Institute of Neurological Disorders and Stroke (U01NS093334)
This publication has 37 references indexed in Scilit:
- A model for the design and implementation of a participant recruitment registry for clinical studies of older adultsClinical Trials, 2012
- Using Alzheimer's disease as a model for genetic risk disclosure: implications for personal genomicsClinical Genetics, 2011
- Genetic counseling and testing for Alzheimer disease: Joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic CounselorsGenetics in Medicine, 2011
- Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trialsAlzheimer's Research & Therapy, 2010
- Barriers and Facilitators of African American Participation in Alzheimer Disease Biomarker ResearchAlzheimer Disease & Associated Disorders, 2010
- Recruitment of a Community-based Cohort for Research on Diversity and Risk of DementiaAlzheimer Disease & Associated Disorders, 2010
- Alzheimer's Prevention Initiative: A Proposal to Evaluate Presymptomatic Treatments as Quickly as PossibleBiomarkers in Medicine, 2010
- Clinical trials: the challenge of recruitment and retention of participantsJournal of Clinical Nursing, 2009
- Recruitment and Retention Strategies for Longitudinal African American Caregiving ResearchJournal of Aging and Health, 2004
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993